Sunshine Coast Haematology and Oncology Clinic, has just taken delivery of new equipment to support and enhance the care of Sunshine Coast cancer patients. The Buderim-based day hospital is the first in Queensland to offer patients a clinically proven, TGA approved scalp cooling treatment that helps in the prevention of hair loss due to certain chemotherapy treatments.
Dr Hong Shue, a leading Sunshine Coast Oncologist, has stated that one of the most frequently asked questions by people considering the options of chemotherapy is … “Am I going to lose my hair?”. Hair loss is widely recognised as one of the most distressing consequences of chemotherapy.
Chemotherapy-induced hair loss (alopecia) not only highlights to the community that a person has cancer, it also has a significant impact on an individual’s quality of life. Clinical Psychologist at the Clinic, Dr Rosanne Middleton, confirms that research suggests that the experience of alopecia (hair loss) is psychologically damaging, and can cause intense emotional suffering, as well as lead to personal, social, and work-related problems. Research suggests that individuals with alopecia have higher levels of anxiety and depression than normal controls, and also experience lower self-esteem, poorer quality of life, and poorer body image. Some research has suggested that for some women, hair loss is reported as being more difficult psychologically, than the loss of a breast through breast cancer.
Scalp cooling is proven to be an effective way of preventing chemotherapy-induced hair loss and can protect the hair follicle from damage. For patients, this means the opportunity to regain some control and encourage a positive attitude towards treatment.
The scalp cooling system can be used with solid tumour cancers in gynaecology, colorectal, breast, prostate and lung cancers that are treated with commonly used chemotherapy drug regimens, as recommended by the treating Oncologist.
The scalp cooling technology has been treating tens of thousands of patients annually throughout the world with a success rate from 56% to 73%. Some studies in the United Kingdom has shown an efficacy rate as high as 89%.
How does it work ? … Chemotherapy works by targeting all rapidly dividing cells in the body. Hair is the second fastest dividing cell. This is the reason why some chemotherapy drugs cause hair loss approximately 2 weeks after the commencement of the chemotherapy treatment. The damage that chemotherapy causes to the hair follicle can be alleviated by using the scalp cooling system
CEO of Montserrat Day Hospitals, Mr Ben Korst, sees this as an important contribution to the cancer community and is in line with our motto of providing “Excellence in Cancer Care”. Our Sunshine Coast Clinic offers a comprehensive service and we are committed to providing leading edge technology to support patient care.
For further information :
Sunshine Coast Haematology and Oncology Clinic – 10 King Street, Buderim
Phone (07) 5479 0000 or www.schoc.com.au